CI

At a glance

ClinicalIndex Comparison Record
Phase 1Completed· 12 enrolled
Drug / intervention
EMIdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06476548
NCT06476548Phase 1Completed
CompareCT.gov

Mindfulness-Based Ecological Momentary Intervention For Smoking Cessation Among Cancer Survivors

H. Lee Moffitt Cancer Center and Research Institute·interventional·Posted Jun 26, 2024·Updated Apr 2, 2026

In Brief

A Phase 1 clinical trial evaluating EMI for Any Cancer Type. Completed, enrolled 12 participants across 1 site.

Detailed Summary

The purpose of the study is to obtain feedback on a new quit-smoking treatment among individuals with a cancer diagnosis using a prototype app we developed.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAny Cancer Type
CountriesUnited States
CollaboratorsNational Cancer Institute (NCI)

Timeline

Phase 1CompletedFinished
20252026
First PostedJun 26, 2024
Enrollment StartJun 12, 2024
Primary CompletionAug 26, 2024
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 2.0 years ago

Interventions

EMIdevice

Participants will complete 3 counseling sessions (30 minutes), download and use a smartphone app for 4 weeks, complete 2 online surveys, and a brief phone call at the end of the study to provide feedback. In the first 3 weeks, participants will use the prototype app every day to complete ecological momentary assessments (EMAs), receive brief mindful skills, and practice formal mindfulness meditations (5-20 minutes). In the final week, participants will continue completing EMAs. Participants will also be provided with nicotine patches.